Finemedix Co., Ltd. (KOSDAQ:387570)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Therapeutic Endoscopy - Clear Grasp Snare	2.44B
Therapeutic Endoscopy - Clear Grasp Snare Growth	17.73%
Therapeutic Endoscopy - Clear-Jet Injection Cather	2.04B
Therapeutic Endoscopy - Clear-Jet Injection Cather Growth	-7.99%
Therapeutic Endoscopy - Clear Cut Knife	1.92B
Therapeutic Endoscopy - Clear Cut Knife Growth	-3.37%
Diagnostic Endoscopy - Clear Bite Forceps	1.10B
Diagnostic Endoscopy - Clear Bite Forceps Growth	-11.18%
Diagnostic Endoscopy - Other	895.00M
Diagnostic Endoscopy - Other Growth	-24.09%
Diagnostic Endoscopy - Clear Tip-FNA/FNB	447.00M
Diagnostic Endoscopy - Clear Tip-FNA/FNB Growth	-4.89%
Therapeutic Endoscopy - Other	264.00M
Therapeutic Endoscopy - Other Growth	149.06%
Therapeutic Endoscopy - Clear Hemograsper	213.00M
Therapeutic Endoscopy - Clear Hemograsper Growth	-34.86%
Other	643.00M
Other Growth	14.82%
Other	643.00M
Other Growth	14.82%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Other	1.38B
South Korea	7.43B
South Korea Growth	-26.79%
Asia	1.14B
Other	1.38B